Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2026-05-14
• Last 15 days FTD volume: £6.61 M
• Last 3 months FTD volume: £35.77 M
• Last 12 months FTD volume: £0.12 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	£66.95 M	£0.17 B	🇺🇸 USA
Pfizer PFE	£62.76 M	£0.15 B	🇺🇸 USA
AbbVie ABBV	£98.72 M	£0.25 B	🇺🇸 USA
Eli Lilly LLY	£62.63 M	£0.42 B	🇺🇸 USA
Amgen AMGN	£0.19 B	£0.42 B	🇺🇸 USA
Biogen BIIB	£5.99 M	£53.39 M	🇺🇸 USA
Illumina ILMN	£9.27 M	£24.4 M	🇺🇸 USA
Vertex Pharmaceuticals VRTX	£50.22 M	£0.12 B	🇺🇸 USA
Merck MRK	£35.72 M	£0.19 B	🇺🇸 USA